Advanced Filters
noise

blood-clots Clinical Trials

A listing of blood-clots medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 219 clinical trials
J Jinhao Lyu, MD

Thrombus Imaging and Treatment Analytics in Neurology

In the present study, the investigators use high-resolution MR vessel wall imaging, and select patients with cerebral and cervical artery occlusion to investigate the relationship between the imaging appearance of thrombus and the various outcome of recanalization treatment.

18 years of age All Phase N/A
P Pieter van Paassen, MD, PhD

Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium

Thrombotic microangiopathy (TMA) is a severe and life-threatening condition, often affecting the kidneys and brain. It can occur on the background of various clinical conditions. Dysregulation of the alternative pathway of complement may be the etiological factor and this type of TMA is classified, according to the current nomenclature, as …

18 years of age All Phase N/A
K Katherine Addy

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.

1 - 98 years of age All Phase N/A

RevCore for In Stent Thrombosis

The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.

18 years of age All Phase N/A
C Christos Bourantas

Flow Patterns and Stent Thrombosis

The goal of this observational study is to study the effect of haemodynamic forces on thrombus formation and identify haemodynamic markers that predict stent thrombosis events in patients who have undergone OCT-guided percutaneous coronary interventions. The primary objective of the study is to examine the efficacy of blood flow patterns …

years of age All Phase N/A
E ERDAL PALA

Thrombophilia and Thrombosis in Behçet's Disease

Behçet's disease (BD) is a systemic vasculitis of unknown cause, affecting mainly young adults. Vasculopathy has been reported in 16.8-51.5% of cases. Genetic, infectious factors, environmental factors, presence of autoantibodies, endothelial pathologies and hypercoagulability are responsible for the etiopathogenesis of BD. The main involvements responsible for morbidity and mortality in …

18 - 70 years of age All Phase N/A
K Kathrine A Friis, PhD-student

Heat Shock Protein 47 in Thrombosis

The goal of this observational study is to learn if the novel biomarker Heat shock protein 47 (HSP47) can be used as a prognostic marker for vascular disease in people with acute venous thromboembolism (VTE), myocardial infarction (AMI) or ischaemic stroke compared to healthy volunteers. The main questions it aims …

18 years of age All Phase N/A
S Stéphane Zuily, MD, PhD

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

This registry, currently being established will ensure consistency of data collection and provide safety information in non high-risk APS patients currently on DOACs.

years of age All Phase N/A

Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy

The goal of this clinical trial is to learn about plasma biomarkers of diagnosed transplant-associated thrombotic microangiopathy (TA-TMA) in patients undergoing transplantation. The main questions it aims to answer are: whether there are molecules that can accurately diagnose and predict TA-TMA; whether the current biomarkers related to TA-TMA can well …

14 - 70 years of age All Phase N/A
P Patricia Casais, MD, PhD

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

The goal of this registry is to gather more information on the efficacy and safety of various antithrombotic regimens. The registry collects data on patients with antiphospholipid syndrome and an arterial event within the past 12 months, on treatment with either A) a VKA with therapeutic range, INR 2.0-3.0 plus …

18 years of age All Phase N/A

Simplify language using AI